Advanced Solid Tumors Harboring KRAS G12C Mutation Clinical Trials in L'Hospitalet de Llobregat, Barcelona

A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation